Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/1995
09/27/1995EP0510003B1 Piperidine and pyrrolidine derivatives
09/26/1995US5453439 Hydroxylamine derivatives
09/26/1995US5453423 Respiratory system disorders
09/26/1995US5453272 Serine-proline-tyrosine-glycine-arginine-cysteine hexapeptide; immunosuppressant
09/26/1995CA2145475A1 Sulfonamidocarbonylpyridine-2-carboxesteramides and their pyridine-n-oxides, process for their preparation, and their use as pharmaceuticals
09/26/1995CA2145432A1 Purine derivatives and pharmaceutically acceptable salts thereof
09/26/1995CA1337122C Pharmacologically active 1,5-diaryl-3-substituted-pyrazoles and method for synthesizing the same
09/21/1995WO1995024920A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
09/21/1995WO1995024903A1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
09/21/1995CA2185324A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
09/20/1995EP0672031A1 Catechol diethers as selective pde iv? inhibitors
09/20/1995EP0671951A1 Humanized antibodies reactive with l-selectin
09/20/1995EP0671927A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus
09/20/1995EP0563358B1 9-substituted bicyclo [3.3.0]octane derivatives, for use as txa2 antagonists
09/20/1995CN1108543A "Houjiling"-medicine made from plum and apricot for curing throat disease and production method thereof
09/20/1995CN1029770C Controlled release bases for pharmaceuticals
09/19/1995US5451700 Leukotriene inhibitors
09/19/1995US5451586 Substance P antagonist
09/19/1995US5451573 Substituted cyclohexane derivatives for the treatment of diseases
09/19/1995CA1337072C 5-substituted [4,5-c] imidazopyridines
09/14/1995WO1995024422A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995WO1995024398A1 Isoxazoline compounds as inhibitors of tnf release
09/14/1995WO1995024397A1 3,5-disubstituted and 3,5,6-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments
09/14/1995WO1995024381A1 Cyano compounds and preparations thereof
09/14/1995WO1995024212A1 The use of interferon subtypes in the preparation of medicaments to treat viral infections
09/14/1995WO1995024207A1 Composition for the treatment of lung disease
09/14/1995WO1995024200A1 Method for treating 5ht2b receptor related conditions
09/14/1995WO1995024192A1 Isoxazoline compounds as 5-lipoxygenase inhibitors
09/14/1995DE4408084A1 3,5-Disubstituierte und 3,4,5-trisubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 3,5-Disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, to processes for their preparation and their use as medicaments
09/14/1995CA2185236A1 Method for treating 5ht2b receptor related conditions
09/14/1995CA2185004A1 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments
09/14/1995CA2184824A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995CA2184385A1 Composition for the treatment of lung disease
09/13/1995EP0671407A2 Sulfated alpha-glycolipid derivatives as cell adhesion inhibitors
09/13/1995EP0670838A1 SUBSTITUTED-PHENYL(N,N'-CYCLOALKYL/ALKYL CARBOXAMIDE)-1H/3H-IMIDAZO 4,5-b]PYRIDINE COMPOUNDS AS PAF ANTAGONISTS
09/13/1995EP0670826A1 Fatty acid derivatives and pharmaceutical compositions containing them
09/13/1995EP0541593B1 Cyclopentane derivatives, process for producing them and their pharmaceutical use
09/13/1995CN1108128A Chinese herbal medicine prepn. for curing pneumonia
09/13/1995CN1108096A Non-peptide tachykinin receptor antagonists
09/12/1995US5449686 4-phenylcyclohexanone derivatives; inhibit production of tumor necrosis factor and phosphodiesterase V
09/12/1995US5449676 Bronchodilator agents
09/12/1995US5449674 Prostaglandin E2 inhibitors
09/12/1995CA1336953C Method of preventing or reducing adverse reactions to protamine using a thromboxane a _receptor antagonist
09/11/1995CA2144019A1 Tetrazolyphenyl pivalate derivatives and medicinal composition containing the same as effective component
09/08/1995WO1995023862A1 Animals with targeted gene disruption
09/08/1995WO1995023854A1 IMPROVED DNase LIQUID SOLUTIONS
09/08/1995WO1995023798A1 Prodrugs of morpholine tachykinin receptor antagonists
09/08/1995WO1995023789A1 Bicyclic carbamates as leukotriene d4 antagonists
09/08/1995WO1995023613A1 PHARMACEUTICALLY ACCEPTABLE DNase FORMULATION
09/08/1995WO1995023602A1 Antitussive composition containing an antitussive and benzydamine
09/06/1995EP0670163A1 Use of pentoxifylline for the manufacture of a medicament for the treatment of fibrosing or granulomatosing lung diseases
09/06/1995EP0669909A1 Substituted amidino compounds, their manufacture and methods of treatment
09/06/1995EP0669833A1 USES OF TGF-$g(b) RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT
09/06/1995CN1107857A Cyclic amino acid derivativges
09/05/1995US5447959 Vitamin A derivatives
09/05/1995US5447943 Novel benzopyran derivatives
09/05/1995US5447942 Treatment of bronchoconstriction
09/05/1995US5447941 Methods of inhibiting pulmonary hypertensive diseases with raloxifene and related benzothiophenes
09/05/1995US5447934 Anti-allergic thiadiazolo [4,3-a]pyridine derivatives
09/05/1995US5447728 A carrier comprising an acylated amino acid; lowering iron concentration in mammals
09/05/1995CA2142154A1 Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors
09/05/1995CA1336891C Use of substituted 3,4-dihydro-2h-benzopyrans as remedies for obstructive functional disorders of the lungs and/or disorders of the efferent urinary passages
09/02/1995CA2143603A1 Fatty acid derivatives
08/1995
08/31/1995WO1995022972A1 Rapamycin derivatives
08/30/1995EP0668770A1 $g(a)-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY
08/30/1995EP0556256B1 Aerosol medicaments
08/30/1995CN1107475A Pyrrolidine derivatives inhibitors of lfukotriene biosynthesis
08/30/1995CN1107473A 4-Arylamino-benzopyran and related compounds
08/30/1995CN1029613C Aryl oxime carbamates and aryl oxime carbonates as bronchodilators and auti-inflamatory agents
08/29/1995US5446131 Polypeptides or cylic polypeptide; therapeutic and prophylactic; inhibit thrombin-induced platelet aggregation
08/29/1995US5446052 Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them
08/29/1995US5446046 1,3-dipropyl-8-(3-oxatricyclo(3,1,2,0(2,4-))oct6(7)-Yl)-xanthine used to treat cadiac arrhythmias
08/29/1995US5446034 Vitamin D analogues
08/29/1995CA2093826C Process for preparing optically active cyanohydrins with enzymes
08/29/1995CA1336833C Piperidine derivatives
08/24/1995WO1995022546A1 Intracellular signalling mediators
08/24/1995WO1995022520A1 Substituted biphenyl derivatives as phosphodiesterase inhibitors
08/24/1995WO1995022329A1 Agent for prophylaxis and treatment of thromboxane a2-mediated diseases
08/24/1995CA2183562A1 Intracellular signalling mediators
08/24/1995CA2182792A1 Substituted biphenyl derivatives as phosphodiesterase inhibitors
08/23/1995EP0668279A2 6-Azaindole thromboxane synthase inhibitors
08/23/1995EP0668075A2 Non-peptide tachykinin receptor antagonists
08/23/1995EP0667858A1 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists
08/23/1995EP0667857A1 Indolylcarbamates as anti-inflammatory agents
08/23/1995EP0667856A1 Novel vitamin d analogues
08/23/1995EP0667855A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
08/23/1995EP0667784A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
08/23/1995CN1107149A 哌嗪衍生物 Piperazine derivatives
08/22/1995US5444050 Binding of E-selectin or P-selectin to sialyl Lewisx or sialyl-Lewisa
08/22/1995US5443833 Pharmaceutical compositions
08/22/1995CA1336773C Therapeutic dibenzo-piperazino-azepine derivatives
08/17/1995WO1995021855A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
08/17/1995WO1995021843A1 Azacyclic derivatives
08/17/1995WO1995021819A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
08/17/1995WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
08/17/1995WO1995021610A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors
08/17/1995CA2182734A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
08/17/1995CA2180006A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
08/16/1995EP0667347A1 Beta-carboline thromboxane synthase inhibitors
08/16/1995EP0666914A1 Novel p-selectin ligand protein